No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment.
Kao WT, Chang CL, Chen YL, Lung FW.
Psychiatr Q · journal article · DOI 10.1007/s11126-014-9309-3 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för paliperidone. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
16 hitsPaliperidone: another treatment option for delusional parasitosis.
Altınöz AE, Tosun Altınöz Ş, Küçükkarapınar M, Coşar B.
Australas Psychiatry · journal article; case reports · DOI 10.1177/1039856214546390Paliperidone protects SK-N-SH cells against glutamate toxicity via Akt1/GSK3β signaling pathway.
Peng L, Zhang X, Cui X, Zhu D, Wu J, Sun D, Yue Q, Li Z, Liu H, Li G, Zhang J, Xu H, Liu F, Qin C, Li M, Sun J.
Schizophr Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.schres.2014.05.037Paliperidone extended release for the treatment of pediatric and adolescent patients with Tourette's disorder.
Yamamuro K, Makinodan M, Ota T, Iida J, Kishimoto T.
Ann Gen Psychiatry · journal article; case reports; case-report · DOI 10.1186/1744-859x-13-13Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.
Mishra J, Kumar A.
Neurotox Res · research support, non-u.s. gov't; journal article · DOI 10.1007/s12640-014-9469-9Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease.
Amatniek J, Canuso CM, Deutsch SI, Henderson DC, Mao L, Mikesell C, Rodriguez S, Sheehan J, Alphs L.
Clin Schizophr Relat Psychoses · research support, non-u.s. gov't; multicenter study; journal articleDosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice.
Peuskens J, Rubio G, Schreiner A.
Ann Gen Psychiatry · review-article; journal article · DOI 10.1186/1744-859x-13-10Clinical effectiveness and resource utilization of paliperidone ER for schizophrenia: Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILAR).
Schreiner A, Hargarter L, Hitschfield K, Lee JI, Lenskaya I, Sulaiman AH, Diels J, PILAR study group.
Curr Med Res Opin · research support, non-u.s. gov't; journal article; observational study · DOI 10.1185/03007995.2014.898630Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics.
Schreiner A, Lahaye M, Peuskens J, Naber D, Dilbaz N, Millet B, Franco MA, Rancans E, Turczynski J, Smeraldi E, Lara E, Neznanov NG.
Expert Opin Pharmacother · research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1517/14656566.2014.884071Paliperidone-associated motor tics.
Hsieh MH, Chiu NY.
Gen Hosp Psychiatry · journal article; case reports · DOI 10.1016/j.genhosppsych.2014.01.003Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system.
Gong W, Liu Y, Mei DY, Yang M, Mei XG.
Drug Dev Ind Pharm · research support, non-u.s. gov't; journal article · DOI 10.3109/03639045.2013.877923Paliperidone for the treatment of ketamine-induced psychosis: a case report.
Zuccoli ML, Muscella A, Fucile C, Carrozzino R, Mattioli F, Martelli A, Orengo S.
Int J Psychiatry Med · journal article; case reports · DOI 10.2190/pm.48.2.cPulmonary thromboembolism due to paliperidone: report of 2 cases.
Şengül MC, Kaya K, Yilmaz A, Şengül C, Serinken M.
Am J Emerg Med · journal article; case reports · DOI 10.1016/j.ajem.2013.12.038Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extended-release paliperidone tablets in patients with schizophrenia.
Yang DS, Seong SJ, Yoon YR, Lim MS, Kwak KH, Lee SJ.
J Psychopharmacol · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1177/0269881113516203Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study.
Gattaz WF, Campos JA, Lacerda AL, Henna E, Ruschel SI, Bressan RA, de Oliveira IR, Rocha FL, Grabowski HM, Sacomani E, Louzã MR, Quevedo J, Elkis H, Zorzetto Filho D, Périco Cde A, Lawson FL, Appolinário JC.
Curr Med Res Opin · clinical trial; research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1185/03007995.2013.869201Postmortem femoral blood concentrations of risperidone.
Linnet K, Johansen SS.
J Anal Toxicol · journal article · DOI 10.1093/jat/bkt096